South Korea biopharma exports hit record $6.6B in Jan-Sep

South Korea's biopharmaceutical exports reached a record $6.6 billion in the first nine months of 2026, indicating sustained growth in the sector. The increase reflects strong global demand for Korean biologics and contract manufacturing, though the breakdown by product and destination is not specified. This underscores Korea's rising role in the global pharmaceutical supply chain.